Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study
Thierry André, Kai Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, C.J.A. Punt, Denis Smith, R. Garcia-Carbonero, Julia Alcaide, Peter Gibbs, Christelle de la Fouchardière, F Rivera, Elena Élez, Dung T. Le, Takashi Yoshino, Yu Zuo, D. Fogelman, David E. Adelberg, Luis A. Díaz
Topics & Concepts
MedicinePembrolizumabMicrosatellite instabilityColorectal cancerOncologyChemotherapyInternal medicineDNA mismatch repairPhases of clinical researchCancerMicrosatelliteImmunotherapyGeneticsGeneAlleleBiologyGenetic factors in colorectal cancerCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies